Literature DB >> 33918210

Impaired Mitochondrial Function in iPSC-Retinal Pigment Epithelium with the Complement Factor H Polymorphism for Age-Related Macular Degeneration.

Mara C Ebeling1, Zhaohui Geng2,3, Rebecca J Kapphahn1, Heidi Roehrich4, Sandra R Montezuma1, James R Dutton2,3, Deborah A Ferrington1,2.   

Abstract

Age-related macular degeneration (AMD), the leading cause of vision loss in the elderly, is characterized by loss of the retinal pigment epithelium (RPE). While the disease mechanism remains unclear, prior studies have linked AMD with RPE mitochondrial defects and genetic polymorphisms in the complement pathway. This study used RPE generated from induced pluripotent stem cells (iPSC-RPE), which were derived from human donors with or without AMD and genotyped for the complement factor H (CFH) AMD high-risk allele (rs1061170, Y402H) to investigate whether donor disease state or genotype had a detrimental effect on mitochondrial function and inflammation. Results show that cells derived from donors with AMD display decreased mitochondrial function under conditions of stress and elevated expression of inflammatory markers compared to iPSC-RPE from individuals without AMD. A more pronounced reduction in mitochondrial function and increased inflammatory markers was observed in CFH high-risk cells, irrespective of disease state. These results provide evidence for a previously unrecognized link between CFH and mitochondrial function that could contribute to RPE loss in AMD patients harboring the CFH high-risk genotype.

Entities:  

Keywords:  age-related macular degeneration; complement factor H; induced pluripotent stem cell; inflammation; mitochondrial function; retinal pigment epithelium

Year:  2021        PMID: 33918210     DOI: 10.3390/cells10040789

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  12 in total

1.  Potential participation of CTRP6, a complement regulator, in the pathology of age related macular degeneration.

Authors:  Katsuhiko Shinomiya; Atsushi Mukai; Eiko Ito; Kazuhito Yoneda; Morio Ueno; Chie Sotozono; Shigeru Kinoshita; Junji Hamuro
Journal:  Jpn J Ophthalmol       Date:  2022-04-09       Impact factor: 2.447

Review 2.  Cell culture models to study retinal pigment epithelium-related pathogenesis in age-related macular degeneration.

Authors:  Kapil Bharti; Anneke I den Hollander; Aparna Lakkaraju; Debasish Sinha; David S Williams; Silvia C Finnemann; Catherine Bowes-Rickman; Goldis Malek; Patricia A D'Amore
Journal:  Exp Eye Res       Date:  2022-07-11       Impact factor: 3.770

3.  Inflammasome Activation in Retinal Pigment Epithelium from Human Donors with Age-Related Macular Degeneration.

Authors:  Mara C Ebeling; Cody R Fisher; Rebecca J Kapphahn; Madilyn R Stahl; Shichen Shen; Jun Qu; Sandra R Montezuma; Deborah A Ferrington
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

4.  Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells.

Authors:  Sujoy Bhattacharya; Jinggang Yin; Weihong Huo; Edward Chaum
Journal:  Stem Cell Res Ther       Date:  2022-06-17       Impact factor: 8.079

5.  Complement Factor H Loss in RPE Cells Causes Retinal Degeneration in a Human RPE-Porcine Retinal Explant Co-Culture Model.

Authors:  Angela Armento; Aparna Murali; Julia Marzi; Ana C Almansa-Garcia; Blanca Arango-Gonzalez; Ellen Kilger; Simon J Clark; Katja Schenke-Layland; Charmaine A Ramlogan-Steel; Jason C Steel; Marius Ueffing
Journal:  Biomolecules       Date:  2021-11-03

6.  Human iPSC- and Primary-Retinal Pigment Epithelial Cells for Modeling Age-Related Macular Degeneration.

Authors:  Cody R Fisher; Mara C Ebeling; Zhaohui Geng; Rebecca J Kapphahn; Heidi Roehrich; Sandra R Montezuma; James R Dutton; Deborah A Ferrington
Journal:  Antioxidants (Basel)       Date:  2022-03-22

Review 7.  Microbiota mitochondria disorders as hubs for early age-related macular degeneration.

Authors:  János Fehér; Ágnes Élő; Lilla István; Zoltán Zsolt Nagy; Zsolt Radák; Gianluca Scuderi; Marco Artico; Illés Kovács
Journal:  Geroscience       Date:  2022-08-18       Impact factor: 7.581

8.  Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration.

Authors:  Mara C Ebeling; Zhaohui Geng; Madilyn R Stahl; Rebecca J Kapphahn; Heidi Roehrich; Sandra R Montezuma; Deborah A Ferrington; James R Dutton
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-04

9.  mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells.

Authors:  David A Merle; Francesca Provenzano; Mohamed Ali Jarboui; Ellen Kilger; Simon J Clark; Michela Deleidi; Angela Armento; Marius Ueffing
Journal:  Antioxidants (Basel)       Date:  2021-12-03

10.  Regulation of ABCA1 by AMD-Associated Genetic Variants and Hypoxia in iPSC-RPE.

Authors:  Florian Peters; Lynn J A Ebner; David Atac; Jordi Maggi; Wolfgang Berger; Anneke I den Hollander; Christian Grimm
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.